Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-08-30
2011-10-04
Davis, Zinna Northington (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S414000, C514S423000, C514S615000, C546S140000, C546S146000, C548S465000, C548S537000, C564S155000
Reexamination Certificate
active
08030341
ABSTRACT:
The present invention relates to symmetric and asymmetric dimeric Dmt (2′,6′-ditnethyl) compounds and Dmt derivative compounds with dual δ and μ opioid receptor antagonist activity. Also, the present invention provides compositions comprising these compounds and it provides methods of using these compounds.
REFERENCES:
patent: 5780589 (1998-07-01), Lazarus et al.
patent: 5811400 (1998-09-01), Schiller
patent: 2002/0161189 (2002-10-01), Lazarus et al.
patent: WO 03/064375 (2003-08-01), None
Arakawa et al.,Transplant. Proc.,24 (2), 696-697 (1992).
Arakawa et al.,Transplant. Proc.,25 (1), 738-740 (1993).
Arakawa et al.,Transplant.,53 (4), 951-953 (1992).
Arunlakshana et al.,Brit. J. Pharmacol.,14, 48-58 (1959).
Balboni et al.,Bioorg. Med. Chem.,11, 5435-5441 (2003).
Balboni et al.,J. Med. Chem.,45, 5556-5563 (2002).
Balboni et al.,Peptides,21, 1663-1671 (2000).
Bryant et al.,Biol. Chem.,378, 107-114 (1997).
Bryant et al.,Trends Pharmacol. Sci.,18, 42-46 (1998).
Capasso et al.,FEBS Lett.,417, 141-144 (1997).
Chappell,Lancet,343, 556 (1994).
Choi et al.,J. Med. Chem.,40, 2733-2739 (1987).
Crescenzi et al.,Eur. J. Biochem.,247, 66-73 (1997).
Ermisch et al.,Physiol. Rev.,73, 489-527 (1993).
Flippen-Anderson et al.,J. Pept. Res.,49, 384-393 (1997).
Froehlich et al.,Alcohol. Clin. Exp. Res.,20, A181-A186 (1996).
Guerrini et al.,Bioorg. Med. Chem.,6, 57-62 (1998).
House et al.,Neurosci. Lett.,198, 119-122 (1995).
Jinsmaa et al.,Eur. J. Pharmacol.,509, 37-42 (2005).
Jinsmaa et al.,J. Med. Chem.,47, 2599-2610 (2004).
Jinsmaa et al.,J. Pharmacol. Exp. Ther.,309, 482-438 (2004).
Jones et al.,J. Pharmacol. Exp. Ther.,262, 638-645 (1992).
Kieffer et al.,PNAS USA,89, 12048-12052 (1992).
Lazarus et al.,Drug Disc. Today,3, 284-294 (1998).
Lazarus et al.,J. Biol. Chem.,264, 354-362 (1989).
Lazarus et al.,J. Med. Chem.,34, 1350-55 (1991).
Lensing et al.,Neuropsychobiol.,31, 16-23 (1995).
Meng et al.,PNAS USA,90, 9954-9958 (1993).
Menkens et al.,Eur. J. Pharm.,219, 346-346 (1992).
Pagé et al.,Bioorg. Med. Chem. Lett.,10, 167-170 (2000).
Portoghese et al.,Eur. J. Pharm.,146, 185-186 (1998).
Salvadori et al.,J. Med. Chem.,42, 5010-5019 (1999).
SALVADORi et al.,Mol. Med.,1, 678-689 (1995).
Santagada et al.,Bioorg. Med. Chem. Lett.,10, 2745-2748 (2000).
Schiller et al.,J. Med. Chem.,36, 3182-3187 (1993).
Schiller et al.,Peptides,483-486 (1994).
Schiller et al.,PNAS USA,89, 11871-11875 (1992).
Temussi et al.,Biochem. Biophys. Res. Commun.,198, 933-939 (1994).
Toth et al.,Proc. lnt. Narc. Res. Conference,72 (2001).
Zukin et al.,PNAS USA,85, 4061-4065 (1988).
Bryant et al.,Biopolymers/Pept. Sci.,71, 86-102 (2003).
Bryant et al.,J. Med. Chem.,45 (25), 5506-5513 (2002).
Coupar,Br. J. Pharmacol.,80, 371-376 (1983).
Evans et al.,Science,258, 1952-1955 (1992).
Horan et al.,J. Pharmacol. Exp. Ther.,265 (3), 1446-1454 (1993).
Pagé et al.,J. Med. Chem.,44 (15), 2387-2390 (2001).
Portoghese,J. Med. Chem.,35 (11), 1927-1937 (1992).
Portoghese,J. Med. Chem.,44 (14), 2259-2269 (2001).
Portoghese,TiPS Reviews,10, 230-235 (1989).
Salvadori et al.,J. Med. Chem.,40 (19), 3100-3108 (1997).
Sasaki et al.Bioorg. Med. Chem.,11, 675-678 (2003).
Weltrowska et al.,J. Peptide Res.,63, 63-68 (2004).
Lazarus Lawrence H.
Li Tingyou
Okada Yoshio
Davis Zinna Northington
Kobe Gakuin University
Leydig , Voit & Mayer, Ltd.
The United States of America as represented by the Secretary of
LandOfFree
Dmt-derivative compounds and related compositions and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dmt-derivative compounds and related compositions and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dmt-derivative compounds and related compositions and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4300039